All Posts:biomedical research
-
Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial
WASHINGTON (May 29, 2020) — A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy. The results […]
Category: News Release
-
Unique “Home Built” Device Provides Fast Disease Analysis in Kidneys Affected by Diabetes
WASHINGTON (May 28, 2020) — The amount of scarring in damaged kidneys as a result of diabetes or acute injury is a key factor in determining treatment. But it has not been possible, using traditional techniques, to quickly and accurately assess how widespread this kind of wounding extends within the organ. Now, however, a physicist […]
Category: News Release
-
Georgetown University Medical Center and MedStar Georgetown University Hospital Collaborate on COVID-19 Antibody Study
WASHINGTON (May 7, 2020) — Georgetown University Medical Center, in collaboration with MedStar Georgetown University Hospital, is conducting a study to test for antibodies in two groups of people with increased vulnerability to COVID-19: hospital workers and those with cancer. The FDA has approved (under an emergency use authorization) only a few tests produced commercially […]
Category: News Release
-
The Storm Surge: COVID-19’s Deadly Weapon
(May 7, 2020) — One of the most chilling aspects about being infected with COVID-19 is that for some people, the trajectory of illness can be highly unpredictable and they can go downhill quickly. For reasons that are not well understood, the immune system can go into overdrive, leading to a deadly cascade of events […]
Category: GUMC Stories
-
NIH Awards $24.3M to Georgetown and Howard Universities to Support Clinical and Translational Research
WASHINGTON (May 1, 2020) — The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) has received a $24.3 million Clinical and Translational Science Award from the National Center for Advancing Translational Science, a part of the National Institutes of Health. The competitive renewal represents the third 5-year award for the center, which has secured […]
Category: News Release
-
Everything Old is New Again: Repurposing Drugs Against COVID-19
(April 30, 2020) — Time is of the essence. With thousands of new cases of COVID-19 being diagnosed worldwide along with hundreds of deaths each day as the first wave of the pandemic spreads in the U.S., finding drugs that prevent or counteract the virus that causes the disease has tremendous urgency for the research […]
Category: GUMC Stories
-
Addressing an Urgent Need: COVID-19 Research at Georgetown
(April 15, 2020) — While the COVID-19 pandemic has presented the medical and scientific community with unrelenting and unparalleled challenges, the unique nature of the virus provides for wide-ranging and potentially impactful areas of scientific exploration and understanding. To that end, Georgetown University Medical Center provided seed money to 15 teams of investigators to better […]
Category: GUMC Stories
-
Donors Get Firsthand Look at How Funds for New Medical Research Are Used
(February 10, 2020) — Current and potential donors to the Partners in Research program were given a rare look into the laboratories where medical tests and drug trials get their start. During the recent “Night at the Lab” tour on the Georgetown University Medical Center campus, participants walked down white halls lined with posters of […]
Category: GUMC Stories
-
Partners in Research Supports Visionary Scientists
(December 14, 2019) — Research is a chicken-and-egg phenomenon. One thing leads to another. But without investigational funding there is no chicken. And no egg. So says Nady Golestaneh, PhD, MSc, adding that she would not be where she is today in her quest to prevent a common blindness in the elderly without small grants […]
Category: GUMC Stories
-
Finding Upends Theory about the Cerebellum’s Role in Reading and Dyslexia
WASHINGTON (October 9, 2019) — New brain imaging research debunks a controversial theory about dyslexia that can impact how it is sometimes treated, Georgetown University Medical Center neuroscientists say. The cerebellum, a brain structure traditionally considered to be involved in motor function, has been implicated in the reading disability known as developmental dyslexia. However, this […]
Category: News Release